logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q3 Earnings Report

Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):

-Earnings: -$14.17 million in Q3 vs. -$11.49 million in the same period last year.
-EPS: -$0.08 in Q3 vs. -$0.07 in the same period last year.
-Analysts projected -$0.12 per share
-Revenue: $18.39 million in Q3 vs. $20.86 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT